AD-MSCs achieved that by inhibiting pro-inflammatory cytokines (TNF-α and IL-12) in activated macrophages, inducing the apoptosis of activated macrophages, suppressing the differentiation/proliferation of Th2 cells, and promoting the differentiation/proliferation of regulatory T cells [100]. The gene discussed is TNF; the disease is Alzheimer disease.